Evidence map›Paper›PMID 36574661›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Inhibition of GPR39 restores defects in endothelial cell-mediated neovascularization under the duress of chronic hyperglycemia: Evidence for regulatory roles of the sonic hedgehog signaling axis.

Sai Pranathi Meda Venkata, Hainan Li, Liping Xu, Jia Yi Koh, Huong Nguyen, Morgan Minjares, Chunying Li, Anjaneyulu Kowluru, Graeme Milligan, Jie-Mei Wang

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Reply to Doboszewska et al.: The many faces of G-protein-coupled receptor 39.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sai Pranathi Meda VenkataDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.ORCID 0000-0002-1771-4806
Hainan LiDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.ORCID 0000-0002-2967-8021
Liping XuDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.
Jia Yi KohDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.
Huong NguyenDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.
Morgan MinjaresDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.
Chunying LiCenter of Molecular and Translational Medicine and the Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30303.ORCID 0000-0003-4040-5689
Anjaneyulu KowluruDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.ORCID 0000-0003-1700-0077
Graeme MilliganInstitute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom.ORCID 0000-0002-6946-3519
Jie-Mei WangDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201.ORCID 0000-0002-8723-4410
Eugene Applebaum College of Pharmacy and Health Sciences · USGeorgia State University · USUniversity of Glasgow · GB

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
NADPH Oxidase, Mitochondrial Dysfunction and Diabetic RetinopathyR01EY022230 · NEI · WAYNE STATE UNIVERSITY · PI KOWLURU, ANJANEYULU, KOWLURU, RENU A. · 2012 to 2022
$3.4M
Training Modules at Wayne State University to Promote Safe and Inclusive EnvironmentsT32GM139807 · NIGMS · WAYNE STATE UNIVERSITY · PI BRYANT-FRIEDRICH, AMANDA C, CHOW, CHRISTINE S · 2021 to 2025
$2.6M
Role of Inositol Requiring Enzyme 1 in Regulating Angiogenesis for Diabetic Wound RepairR01DK109036 · NIDDK · WAYNE STATE UNIVERSITY · PI WANG, JIEMEI · 2016 to 2020
$1.7M
Mechanistic study of Small-molecular Therapy in diabetic Wound HealingR01DK128937 · NIDDK · WAYNE STATE UNIVERSITY · PI WANG, JIEMEI, YI, ZHENGPING · 2021 to 2024
$1.6M
Alleviating Reactive Carbonyl Species-Induced Progenitor Cell Dysfunction in Diabetic Wound HealingR01DK119222 · NIDDK · WAYNE STATE UNIVERSITY · PI MONKS, TERRENCE J., WANG, JIEMEI · 2019 to 2022
$1.5M
Islet Beta-Cell Dysfunction Under Metabolic StressI01BX004663 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KOWLURU, ANJANEYULU · 2020 to 2023
–
BLRD Research Career Scientist Award ApplicationIK6BX005383 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI Anjaneyulu Kowluru · 2021 to 2026
–
BLRD VA I01 BX004663BLRD VA IK6 BX005383NEI NIH HHS R01 EY022230NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK109036NIDDK NIH HHS R01 DK119222NIDDK NIH HHS R01 DK128937NIGMS NIH HHS T32 GM139807
6 · The paper itself

Abstract

Impaired endothelial cell (EC)-mediated angiogenesis contributes to critical limb ischemia in diabetic patients. The sonic hedgehog (SHH) pathway participates in angiogenesis but is repressed in hyperglycemia by obscure mechanisms. We investigated the orphan G protein-coupled receptor GPR39 on SHH pathway activation in ECs and ischemia-induced angiogenesis in animals with chronic hyperglycemia. Human aortic ECs from healthy and type 2 diabetic (T2D) donors were cultured in vitro. GPR39 mRNA expression was significantly elevated in T2D. The EC proliferation, migration, and tube formation were attenuated by adenovirus-mediated GPR39 overexpression (Ad-GPR39) or GPR39 agonist TC-G-1008 in vitro. The production of proangiogenic factors was reduced by Ad-GPR39. Conversely, human ECs transfected with GPR39 siRNA or the mouse aortic ECs isolated from GPR39 global knockout (GPR39

Indexed as

Diabetes Mellitus, Type 2HyperglycemiaAnimalsCells, CulturedEndothelial CellsHedgehog ProteinsHumansIschemiaMiceNeovascularization, PathologicNeovascularization, PhysiologicReceptors, G-Protein-CoupledZinc Finger Protein GLI1GPR39 protein, humanGPR39 protein, mouseHedgehog ProteinsReceptors, G-Protein-CoupledZinc Finger Protein GLI1angiogenesisendothelial functionG protein–coupled receptor 39hyperglycemialimb ischemia

Identifiers

PMID36574661
PMCPMC9910611
OpenAlexW4313251120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.